New Ray Medicine International Holdings Limited issued a notice to non-registered shareholders on September 19, 2024, announcing that its 2024 interim report is available on the company's and Hong Kong Stock Exchange websites. The company encourages shareholders to read the report on the website and provides options for shareholders to request a printed version if needed. The company will notify shareholders via email or mail, provided that shareholders have provided valid contact information through banks, brokers, custodians, and other intermediary institutions. If shareholders fail to provide contact information, they will not receive the notification. Shareholders can contact the share registration branch during working hours for inquiries.

New Ray Medicine International Holdings Limited issued a notice to non-registered shareholders on September 19, 2024, announcing that its 2024 interim report is available on the company's and Hong Kong Stock Exchange websites. The company encourages shareholders to read the report on the website and provides options for shareholders to request a printed version if needed. The company will notify shareholders via email or mail, provided that shareholders have provided valid contact information through banks, brokers, custodians, and other intermediary institutions. If shareholders fail to provide contact information, they will not receive the notification. Shareholders can contact the share registration branch during working hours for inquiries.